通过非网格蛋白、非降解途径将聚合物纳米颗粒优先递送至活细胞的核周区域。

Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway.

作者信息

Lai Samuel K, Hida Kaoru, Man Stan T, Chen Clive, Machamer Carolyn, Schroer Trina A, Hanes Justin

机构信息

Department of Chemical and Biomolecular Engineering, Johns Hopkins University, 3400 N. Charles St., Baltimore, MD 21218, USA.

出版信息

Biomaterials. 2007 Jun;28(18):2876-84. doi: 10.1016/j.biomaterials.2007.02.021. Epub 2007 Feb 27.

Abstract

The efficacy of many therapeutic molecules could be greatly enhanced by polymer-based nanoparticle systems capable of delivering them to the direct vicinity of the cell nucleus. However, degradation of the particles and encapsulated drugs within the enzyme-rich and low-pH environments of the endo/lysosomal pathway of cells has dramatically limited the efficacy of such systems. In this paper, we discovered that small polymeric particles (<25 nm) but not larger particles (>42 nm) enter live cells via a novel mechanism that leads to trafficking outside the endo/lysosomal pathway. Sub-25 nm particles rapidly transport to the perinuclear region of cells in vesicles that never acidify. The pathway is non-degradative, cholesterol independent, and non-clathrin and non-caveolae mediated. This privileged non-acidic pathway may be general since our results are surprisingly obtained with standard latex polymer beads without addition of ligands and may, therefore, provide a promising route for drug and gene delivery using biomaterial-based nanodevices.

摘要

许多治疗性分子的疗效可以通过基于聚合物的纳米颗粒系统得到极大提高,这些系统能够将它们递送至细胞核的直接附近区域。然而,在细胞内吞/溶酶体途径富含酶且低pH的环境中,颗粒和包封药物的降解显著限制了此类系统的疗效。在本文中,我们发现小的聚合物颗粒(<25 nm)而非较大颗粒(>42 nm)通过一种导致在内吞/溶酶体途径外进行运输的新机制进入活细胞。小于25 nm的颗粒在从不酸化的囊泡中迅速运输至细胞的核周区域。该途径是非降解性的,不依赖胆固醇,且不是由网格蛋白和小窝介导的。这种特殊的非酸性途径可能具有普遍性,因为我们的结果是在未添加配体的标准乳胶聚合物珠上令人惊讶地获得的,因此可能为使用基于生物材料的纳米装置进行药物和基因递送提供一条有前景的途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索